Dai, xiaohua – Trademark Portfolio
Entity Type: 01
Dai, xiaohua owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as OUFEX, RYDOX, VYSGEO, and GEOGROW. Of these, 4 are registered. The portfolio spans 5 Nice Classification classes, led by Class 11 (Environmental Control) and Class 27 (Floor Coverings). Headquartered in Shenzhen City.
27D, building 3,
Jinglong building, Futian District
Shenzhen City 518034 , CN
Showing of trademarks Trademarks
Trademark Classifications
Dai, xiaohua's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Precious metals and their alloys; jewellery, precious stones; horological instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Dai, xiaohua have?
Dai, xiaohua has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Dai, xiaohua file in?
Dai, xiaohua files trademarks across 5 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 27 (Floor Coverings), Class 14 (Jewelry), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.
What are Dai, xiaohua's most well-known trademarks?
Dai, xiaohua's registered trademark portfolio includes well-known marks such as OUFEX, RYDOX, VYSGEO, and GEOGROW. These are among 4 currently registered trademarks in the portfolio.
What is Dai, xiaohua's trademark registration success rate?
Dai, xiaohua has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.